1. Anglade P, Vyas S, Javoy-Agid F, Ilerreto MT, Michel PP, Marquez J, Pouatt-Prigent A, Ruberg M, Hirsch C, Agid Y (1997) Apotosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol Histopathol 12: 25–31
2. Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch H (1994) Immunocytochemical analysis of tumor necrosis factor and its receptor in Paekinson’s disease. Neurosci Lett 172: 151–154
3. Braak H, Müller CM, Rüb U, Ackermann H, Bratzke H, de Vos Rai RAI, Del Tredici K (2006) Pathology associated with sporadic Parkinson’s disease — where does it end? J Neural Transm Suppl 70: 89–97
4. Bringmann G, Brückner R, Münchbach M, Feinei D, God R, Wesemann W, Grote C, Herderich M, Diem S, Lesch K-P, Mössner R, Storch A (2000) Clonal-derived mammalian alkaloid with neurotoxic properties. “TaClo”. In: Storch A, Collins MA (eds) Neurotoxic factors in Parkinson’s disease and related disorders. Kluwer Academic Publishing/Plenum, New York, pp 145–149
5. Collins MA, Neafsey El (2000) β-Carboline analogues of MPP+ as environmental neurotoxins. In: Storch MA, Collins MA (eds) Neurotoxic factors in Parkinson’s disease and related disorders. Kluwer Academic Publishing/Plenum, New York, pp 115–130